1. Home
  2. KELYA vs AQST Comparison

KELYA vs AQST Comparison

Compare KELYA & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kelly Services Inc.

KELYA

Kelly Services Inc.

N/A

Current Price

$13.76

Market Cap

576.2M

ML Signal

N/A

Logo Aquestive Therapeutics Inc.

AQST

Aquestive Therapeutics Inc.

N/A

Current Price

$3.57

Market Cap

529.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KELYA
AQST
Founded
1946
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
576.2M
529.4M
IPO Year
1994
2007

Fundamental Metrics

Financial Performance
Metric
KELYA
AQST
Price
$13.76
$3.57
Analyst Decision
Buy
Strong Buy
Analyst Count
3
9
Target Price
★ $20.00
$9.33
AVG Volume (30 Days)
296.0K
★ 2.2M
Earning Date
11-05-2026
11-03-2026
Dividend Yield
★ 2.13%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.10
N/A
Revenue
N/A
★ $67,430,000.00
Revenue This Year
N/A
$14.58
Revenue Next Year
$3.70
$32.78
P/E Ratio
$112.73
★ N/A
Revenue Growth
N/A
★ 0.77
52 Week Low
$7.98
$2.94
52 Week High
$17.75
$6.74

Technical Indicators

Market Signals
Indicator
KELYA
AQST
Relative Strength Index (RSI) 31.28 32.82
Support Level $8.79 $2.94
Resistance Level $16.61 $4.34
Average True Range (ATR) 0.79 0.22
MACD -0.23 -0.03
Stochastic Oscillator 8.70 6.08

Price Performance

Historical Comparison
KELYA
AQST

About KELYA Kelly Services Inc.

Kelly Services Inc is a specialty talent solutions company. The company operates through three reportable segments: i) Enterprise Talent Management, which provides temporary staffing, outsourcing, and permanent placement services across industrial, contact center, and clerical roles, ii) Science, Engineering & Technology, which supplies specialized talent across multiple industries, and iii) Education, which delivers staffing, placement, and executive search services to Pre-K-12 school districts and education organizations in the United States. The majority of the company's revenue is derived from the Enterprise Talent Management segment. Geographically, it generates the maximum revenue from the United States, followed by Europe and the Asia-Pacific Region.

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Share on Social Networks: